Stocks to keep an eye on July, 02 2015

( click to enlarge )
Juno Therapeutics Inc (NASDAQ:JUNO) starting to get some momo once again on 30m chart. The stock showed buying strength all day. The 55-55.38 area is a critical resistance region that can determine overall bias for the stock in short-term. Above this level could test 60 next. I loaded up few more shares today. Note also that the MACD is about to make a bullish cross. On watch.

( click to enlarge )
Micron Technology, Inc. (NASDAQ:MU) There was an unusually high call options activity today (strike $20 JAN2017). I believe this could signal a bottom. On the hourly time frame, technical indicators are giving some positive divergences. As noted yesterday, the bounce could start at any time.

( click to enlarge )
Orexigen Therapeutics, Inc.(NASDAQ:OREX) is looking good to me. I am very pleased about how the stock has pulled back to its EMA13 after its large move on Monday. For the coming days, a breakout above the 5.19 level would signal the start of a new uptrend that could potentially test the EMA200 around the 5.80 area.

( click to enlarge )
AeroVironment, Inc. (NASDAQ:AVAV) broke out and closed above the key resistance level of 28.92 on a nice volume increase. If the technical chart does what is supposed to do the stock will be going higher in the days to come.

Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.